We Can Help
We understand the challenges oncologists face. Our solutions benefit your patients and you, their provider.
We help you improve Patient:
- Satisfaction Scores
We give people affected by cancer the treatment and tools needed to decrease distress and improve their overall quality of life.
- Care Pathway Compliance
Overwhelming fatigue, pain, numbness and tingling, and decreased functional ability are all potential side effects of cancer treatment. When these side effects become too burdensome, cancer treatment may be delayed or stopped. Cancer rehabilitation can potentially help by developing individualized programs with goals of maintaining or improving functional status, mobility, physical activity and decreasing pain and/or fatigue.
- Reimbursement and Value-Based Scores
We help cancer survivors manage pain, balance, walking issues and excessive fatigue through individualized physical activity programs. This guidance can potentially decrease unnecessary emergency room visits, the risk of falls and office call-backs.
Partnering with ReVital
A significant number of the 15.5 million people affected by cancer in the United States report lower long-term low physical quality of life than those without cancer.1,2,3 Preventing decline while restoring and maintaining function and quality of life is the primary mission of ReVital.
Whether you’re part of a small independent oncology practice or large hospital-based network, we seek to partner with oncology practices committed to high-quality care throughout the cancer journey.
We know your plate is full. That’s why we developed a simple referral process to provide your patients with the specialized care and support they need so you can focus on saving more lives. Not only will your patients appreciate the opportunity to engage in their own care, your team will benefit by partnering with a rehabilitation provider dedicated to cancer care.
- Weaver KE, Forsythe LP, Reeve BB, et al. Mental and Physical Health–Related Quality of Life among U.S. Cancer Survivors: Population Estimates from the 2010 National Health Interview Survey. Cancer Epidemiology Biomarkers & Prevention.
- Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA: a cancer journal for clinicians. 2016;66(4):271-289.
- Kent EE, Ambs A, Mitchell SA, Clauser SB, Smith AW, Hays RD. Health‐related quality of life in older adult survivors of selected cancers: Data from the SEER‐MHOS linkage. Cancer. 2015;121(5):758-765.
- Joseph SC, Barnard S, Macduff C, Moffat M, Walker P, Diack L. Users' perceptions of interprofessional collaborative care during their cancer journeys'. 201
- Mittmann N, Beglaryan H, Liu N, et al. Examination of Health System Resources and Costs Associated With Transitioning Cancer Survivors to Primary Care: A Propensity-Score–Matched Cohort Study. Journal of Oncology Practice. 2018:JOP.18.00275.
- Kolb NA, Smith AG, Singleton JR, et al. The association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling. JAMA neurology. 2016;73(7):860-866.
- Aprile G, Pisa F, Follador A, et al. Unplanned presentations of cancer outpatients: a retrospective cohort study. Supportive Care in Cancer. 2013;21(2):397-404.
- Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. Journal of Clinical Oncology. 2011;29(25):3457.